Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gottardo, N. G.
Right arrow Articles by Gajjar, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottardo, N. G.
Right arrow Articles by Gajjar, A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Brain Cancer
*Childhood Brain Tumors
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Chemotherapy for Malignant Brain Tumors of Childhood

Nicholas G. Gottardo, MD

Division of Neuro-Oncology, Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 North Lauderdale St, Memphis, Tennessee

Amar Gajjar, MD

Division of Neuro-Oncology, Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 North Lauderdale St, Memphis, Tennessee, amar.gajjar{at}stjude.org

During the past 3 decades, chemotherapeutic agents for the treatment of pediatric brain tumors have been extensively evaluated in a myriad of schedules, doses, and combinations. Remarkable advances in outcome have been achieved for certain children, notably those with medulloblastoma, but with a high cost to quality of life. In addition, the success achieved for medulloblastoma is offset by lack of progress for high-grade glioma. Despite intensive investigation, no single chemotherapeutic regimen stands out for children with high-grade glioma, with most succumbing to their disease. Further treatment intensification using conventional nonspecific chemotherapy is more likely to result in additional toxicity without major advances in survival. Genome-wide analysis using microarray technology has contributed significantly to our understanding of tumor biology, shifting the focus onto novel agents that target molecular changes crucial for tumor proliferation or survival. These selective agents are likely to be less toxic to normal cells and more effective.

Key Words: chemotherapy • brain tumors • pediatric

References

  • Cbtrus. Statistical report: primary brain tumors in the United States, 1998-2002. Central Brain Tumor Registry of the United States, 2005.
  • Gajjar A., Chintagumpala M., Ashley D., et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7:813-820.[Web of Science][Medline] [Order article via Infotrieve]
  • Packer RJ, Gajjar A., Vezina G., et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202-4208.[Abstract/Free Full Text]
  • Hoppe-Hirsch E., Reiner D., Lellouch-Tubiana A., Sainte-Rose C., Pierre-Kahn A., Hirsch JF Medulloblastoma in childhood: progressive intellectual deterioration. Childs Nerv Syst. 1990;6: 60-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Silber JH, Radcliffe J., Peckham V., et al. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol. 1992;10:1390-1396.[Abstract/Free Full Text]
  • Mulhern RK, Merchant TE, Gajjar A., Reddick WE, Kun LE Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5:399-408.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Laughton SJ, Merchant TE, Sklar CA, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol. 2008;26:1112-1118.[Abstract/Free Full Text]
  • Broniscer A., Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist. 2004;9:197-206.[Abstract/Free Full Text]
  • Gajjar A., Mulhern RK, Heideman RL, et al. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol. 1994;12:1212-1216.[Abstract/Free Full Text]
  • Walter AW, Mulhern RK, Gajjar A., et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol. 1999;17:3720-3728.[Abstract/Free Full Text]
  • Davis FG, Freels S., Grutsch J., Barlas S., Brem S. Survival rates in patients with primary brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg. 1998;88:1-10.[Web of Science][Medline] [Order article via Infotrieve]
  • Packer RJ, Goldwein J., Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol. 1999;17:2127-2136.[Abstract/Free Full Text]
  • Taylor RE, Bailey CC, Robinson K., et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic (M0-M1) medulloblastoma. The SIOP/UKCCSG PNET-3 study. J Clin Oncol. 2003;21: 1581-1591.[Abstract/Free Full Text]
  • Kortmann RD, Kuhl J., Timmermann B., et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood, results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys. 2000;46:269-279.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Taylor RE, Bailey CC, Robinson KJ, et al. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/ UKCCSG PNET III chemotherapy. Eur J Cancer. 2005;41: 727-734.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Packer RJ, Sutton LN, Elterman R., et al. Outcome of children with medulloblastoma treated with radiation, cisplatin, CCNU and vincristine chemotherapy. J Neurosurg. 1994;81: 690-698.[Web of Science][Medline] [Order article via Infotrieve]
  • Evans AE, Jenkin RDT, Sposto R., et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg. 1990;72:572-582.[Web of Science][Medline] [Order article via Infotrieve]
  • Tait DM, Thornton-Jones H., Bloom HJ, Lemerle J., Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-center control trial of the International Society of Pediatric Oncology (SIOP). Eur J Cancer. 1990;26:464-469.[Web of Science][Medline] [Order article via Infotrieve]
  • Deutsch M., Thomas PR, Krischer J., et al. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg. 1996;24:167-177.[Web of Science][Medline] [Order article via Infotrieve]
  • Thomas PR, Deutsch M., Kepner JL, et al. Low-stage medulloblastoma: final analysis of trial comparing standard dose with reduced dose neuraxis irradiation. J Clin Oncol. 2000;18: 3004-3011.[Abstract/Free Full Text]
  • Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group Study. J Clin Oncol. 1998;16: 1723-1728.[Abstract]
  • Bailey CC, Gnekow A., Welleck S., et al. Prospective randomized trial of chemotherapy given before radiotherapy of childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO) SIOP II. Med Pediatr Oncol. 1995;25:166-178.[Web of Science][Medline] [Order article via Infotrieve]
  • Hughes EN, Shilito J., Sallan SE, Loeffler JS, Cassady JR, Tarbell NJ Medulloblastoma at the joint center for radiation therapy between 1968 and 1984: the influence of radiation dose and pattern of failure. Cancer. 1988;61:1992-1998.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tarbell NJ, Friedman HS, Kempner J., et al. Outcome of children with high stage medulloblastoma: results of the Pediatric Oncology Group 9031 study. Int J Radiat Oncol Biol Phys. 2000;48:134.
  • Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17:832-845.[Abstract/Free Full Text]
  • Pomeroy SL, Tamayo P., Gaasenbeek M., et al. Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature. 2002;415:436-442.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Thompson MC, Fuller C., Hogg T., et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol. 2006;24:1924-1931.[Abstract/Free Full Text]
  • Gilbertson RJ, Ellison DW The origins of medulloblastoma subtypes. Annu Rev Pathol. 2008;3:341-65.[CrossRef][Medline] [Order article via Infotrieve]
  • Gajjar A., Hernan R., Kocak M., et al. Clinical, histopathological, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004;22:984-993.[Abstract/Free Full Text]
  • Gilbertson R., Gajjar A. Molecular biology of medulloblastoma: will it ever make a difference to clinical management? J Neurooncol. 2005;75:273-278.[CrossRef][Medline] [Order article via Infotrieve]
  • Finlay JL, Boyett JM, Yates AJ, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's Cancer Group. J Clin Oncol. 1995;13:112-123.[Abstract/Free Full Text]
  • Sposto R., Ertel IJ, Jenkin RD, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Children's Cancer Study Group. J Neurooncol. 1989;7:165-177.[CrossRef][Medline] [Order article via Infotrieve]
  • Pollack IF, Boyett JM, Yates AJ, et al. The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro Oncol. 2003;5: 197-207.[Abstract]
  • Wolff JE, Gnekow AK, Kortmann RD, et al. Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer. 2002;94:264-271.[CrossRef][Medline] [Order article via Infotrieve]
  • Stupp R., Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.[Abstract/Free Full Text]
  • Stupp R., Hegi ME, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol. 2007;25:4127-4136.[Abstract/Free Full Text]
  • Hegi ME, Diserens AC, Gorlia T., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997-1003.[Abstract/Free Full Text]
  • Broniscer A., Chintagumpala M., Fouladi M., et al. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol. 2006;76:313-319.[CrossRef][Medline] [Order article via Infotrieve]
  • Phillips HS, Kharbanda S., Chen R., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157-173.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rich JN, Bigner DD Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 2004;3:430-446.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Khanna C., Helman LJ Molecular approaches in pediatric oncology. Annu Rev Med. 2006;57:83-97.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kerbel RS Antiangiogenic therapy: a universal chemosensitization strategy for cancer? Science. 2006;312:1171-1175.[Abstract/Free Full Text]
  • Vredenburgh JJ, Desjardins A., Herndon JE 2nd, et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol. 2007;25:4722-4729.[Abstract/Free Full Text]
  • Hargrave D., Bartels U., Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7:241-248.[CrossRef][Medline] [Order article via Infotrieve]
  • Dunkel IJ, Garvin JH Jr, Goldman S., et al. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol. 1998;37:67-73.[CrossRef][Medline] [Order article via Infotrieve]
  • Packer RJ, Allen JC, Goldwein JL, et al. Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy. Ann Neurol. 1990;27:167-173.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328:1725-1731.[Abstract/Free Full Text]
  • Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol. 1999;1:152-161.[CrossRef][Medline] [Order article via Infotrieve]
  • Geyer JR, Sposto R., Jennings M., et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol. 2005;23:7621-7631.[Abstract/Free Full Text]
  • Grill J., Sainte-Rose C., Jouvet A., et al. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol. 2005;6:573-580.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rutkowski S., Bode U., Deinlein F., et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978-986.[Abstract/Free Full Text]
  • Dhall G., Grodman H., Ji L., et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the ``Head Start'' I and II protocols. Pediatr Blood Cancer. 2008;50:1169-1175.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. 2004;22:4881-4887.[Abstract/Free Full Text]
  • Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol. 1994;12:1607-1615.[Abstract/Free Full Text]
  • Abstract from 9th International Symposium on Pediatric Neuro-oncology (ISPNO), June 2000.
  • Packer RJ, Biegel JA, Blaney S., et al. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol. 2002;24:337-342.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kleihues P., Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215-225.[Web of Science][Medline] [Order article via Infotrieve]
  • Tekautz TM, Fuller CE, Blaney S., et al. Atypical teratoid/ rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylatorbased chemotherapy. J Clin Oncol. 2005;23:1491-1499.[Abstract/Free Full Text]
  • Kieran MW, Turner CD, Rubin JB, et al. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol. 2005;27:573-581.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Child Neurology, Vol. 23, No. 10, 1149-1159 (2008)
DOI: 10.1177/0883073808321765
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
R. A. Brumback
Child Neurologists Should Be Interested In Brain Tumors!
J Child Neurol, November 1, 2009; 24(11): 1338 - 1340.
[PDF]

Home page
 Cancer Res.Home page
J. Shen, A. M. Carcaboso, K. E. Hubbard, M. Tagen, H. G. Wynn, J. C. Panetta, C. M. Waters, M. A. Elmeliegy, and C. F. Stewart
Compartment-Specific Roles of ATP-Binding Cassette Transporters Define Differential Topotecan Distribution in Brain Parenchyma and Cerebrospinal Fluid
Cancer Res., July 15, 2009; 69(14): 5885 - 5892.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gottardo, N. G.
Right arrow Articles by Gajjar, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottardo, N. G.
Right arrow Articles by Gajjar, A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Brain Cancer
*Childhood Brain Tumors
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?